Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 2 | GULAB MEDICOSELikely | 1 | ₹1,380 |
| 2 | Schedule 3 | Not yet disclosed by govt.Likely | 18 | - |
| 3 | Schedule 5 | NUTRAKEM INDIA PRIVATE LIMITEDLikely | 1 | - |
| 4 | Schedule 7 | Not yet disclosed by govt.Likely | 18 | - |
| 5 | Schedule 8 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITEDLikely | 1 | ₹652.80 |
Tender Value
₹48,018.36
EMD Value
Exempted
Closing Date
9 Apr 2025, 6:00 pmClosed
Tab Nasal Decongestant Phenyl Propanolamine with Chlorpeniramine
Para dichlorobenzene 2 percent w by v benzocaine 2 point 7 percent w by v chlorbutol 5 percent turpentine oil 15 percent w by v eye drop bott of 10 ml
Metronidazole Susp 200 mg per 5 ml bott of 60 ml
Norflox Syp 100 mg per 5 ml bott of 30 ml
Iron drop Paed containing Ferrous Fumarate 25 mg per ml vit B 12 12 point 5 mg per ml and folic acid 200 mg per ml bott of 15 ml
Roxythromycin 50 mg per 5 ml Syp in bott of 30 ml
Syp Calcium Phosphate 80 mg per 5 ml 200 ml bott
Alprazolam 0 poitnr 25 mg tab
Clonazepam 0 point 5 mg Tab
Escitalopram 10 mg Tab
Haloperidol 5 mg per ml Inj
Nortriptyline 25 mg Tab
Promethazine Hcl 25 mg Tab
Syp Sucralfate 1000 mg per 10 ml plus Oxetacaine 10 mg per 10 ml bott of 100 ml
Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 per ml 2 ml Inj
Beclomethasone diporopionate 50 mcg salbutamol as sulphate 100 mcg per meter dose aerosol 200 doses unit
Formeterol 20 mcg plus Budesonide 0 point 5 mg respules
Ipratroium Bromide Respiratory Sol 500 mcg per 2 ml respules
Cough expectorant Syp each 5 ml containing Diphenhydramine Hcl 14 point 08 mg ammonium chloride 0 point 138 gm sodium citrate 57 point 03 mg menthol 1 point 14 mg in flavoured Syp base bott of 100 ml
Cough Lozenges Tab
Dextrose Inj 25 percent 25 ml Inj
Potassium Chloride Liquid 20 percent bott of 200 ml
Glucosamine 500 mg Tab
Antacid Chewable containing dried aluminium hydroxide IP 250 mg Mag Hydroxide NF 250 mg Methyl Polysiloxane 50 mg Tab Bid Number ( ) : GEM/2025/B/6070902 Dated : 19-03-2025 Bid Document 1/24
7661132
GEM/2025/B/6070902
Two Packet Bid
Tab Nasal Decongestant Phenyl Propanolamine with
30 days
Ladakh; Leh Ladakh
Item wise evaluation
BOQ
6 documents required · 6 mandatory
3 yrs
₹31
80%
Exempted
9 Apr 2025
19 Mar 2025
9 Apr 2025
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 1 | Tab Nasal Decongestant Phenyl Propanolamine with Chlorpeniramine | 120 | No | Leh | 30 | |
| 2 | Para dichlorobenzene 2 percent w by v benzocaine 2 point 7 percent w by v chlorbutol 5 percent turpentine oil 15 percent w by v eye drop bott of 10 ml | 120 | Bott | Leh | 30 | |
| 3 | Metronidazole Susp 200 mg per 5 ml bott of 60 ml | 60 | Bott | Leh | 30 | |
| 4 | Norflox Syp 100 mg per 5 ml bott of 30 ml | 144 | Bott | Leh | 30 | - |
| 5 | Iron drop Paed containing Ferrous Fumarate 25 mg per ml vit B 12 12 point 5 mg per ml and folic acid 200 mg per ml bott of 15 ml | 24 | Bott | Leh | 30 | |
| 6 | Roxythromycin 50 mg per 5 ml Syp in bott of 30 ml | 240 | Bott | Leh | 30 | - |
| 7 | Syp Calcium Phosphate 80 mg per 5 ml 200 ml bott | 24 | Bott | Leh | 30 | |
| 8 | Alprazolam 0 poitnr 25 mg tab | 1,920 | No | Leh | 30 | - |
| 9 | Clonazepam 0 point 5 mg Tab | 960 | No | Leh | 30 | |
| 10 | Escitalopram 10 mg Tab | 24 | No | Leh | 30 | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7661132.pdf
GEM_BID
item_specification_rr_bns_re_13_25-26_2025-03-19-17-40-03_a4995589a9c862803a53889cec49a5b4.pdf
BOQ
csv_file_rr_bn_re_13_2025-03-19-17-40-03_8a9da2ef516083976e1bbfc2b4058b8c.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .